Dr. Brar is the Program Director of Residency at Mount Sinai Hospital and is also an Assistant Professor at University of Toronto. Sav is a graduate of the medical school at the University of Western Ontario and obtained his residency training in General Surgery at the University of Calgary. Following residency, he obtained his MSc in Health Economics, Policy and Management at the London School of Economics and Political Science in London, UK. His academic interests include education, health policy and economic evaluations in surgery.
Dr. Rebecca Gladdy is a Surgeon Scientist and Associate Professor at the University of Toronto, who joined the faculty in 2008 after completing a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. Her independent research program at the Lunenfeld-Tanenbaum Research Institute is focused on developing functional genomics platforms to inform the development of much-needed effective therapies for sarcoma patients. Her clinical expertise is in the surgical management of soft tissue sarcoma.
Dr. Gladdy is a member of the Sarcoma Program, which is the Centre of Excellence for Sarcoma Care in Canada and is affiliated with Princess Margaret Cancer Centre, Mount Sinai Hospital (MSH) and the Hospital for Sick Children. In addition to running a translational research lab, she is the Director of the GI Sarcoma Clinical Research Group at MSH, which is dedicated to advancing clinical care through engaging in clinical trials and improving quality of life for sarcoma patients.
Dr. Swallow is a Surgical Oncologist at The Princess Margaret/Mount Sinai Hospital in Toronto. She graduated from the University of Toronto Medical School, and trained in the General Surgery residency program at University of Toronto as a member of the Surgical Scientist Training Program, completing a PhD in cell biology and surgical sepsis. After this she completed clinical fellowship training in Surgical Oncology at Memorial Sloan Kettering Cancer Center.
She is currently a Professor in the Department of Surgery and Institute of Medical Science at the University of Toronto. Her areas of clinical expertise include retroperitoneal sarcoma, gastrointestinal stromal tumour, gastric cancer, and rectal cancer. Her laboratory research is focused on cell cycle regulation and carcinogenesis.
Dr. Swallow is the Director of the University of Toronto General Surgical Oncology Fellowship Program, the Head of the Division of General Surgery at Mount Sinai Hospital, the Chair of the Royal College General Surgical Oncology Specialty Committee, and the President-Elect of the Canadian Society of Surgical Oncology. She is the author of more than 50 peer-reviewed papers.
Back to Surgical Oncology